The use of nasal allergen vs allergen exposure chambers to evaluate allergen immunotherapy

Hossenbaccus, L; Ellis, AK

Ellis, AK (corresponding author), Kingston Gen Hosp, Watkins 1D,76 Stuart St, Kingston, ON K7L 2V7, Canada.

EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2021; 17 (5): 461

Abstract

Introduction Allergen-specific immunotherapy (AIT) is the only disease-modifying treatment option for allergic rhinitis (AR) patients with persistent ......

Full Text Link